Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Jill Hallin in Cancer Research
Introduction: Jill Hallin is a prominent inventor based in San Diego, CA, known for her significant contributions to cancer research. With a focus on innovative therapies, she has been instrumental in developing treatments for KRas G12C cancers. Her work has led to the filing of 3 patents, showcasing her dedication to advancing medical science.
Latest Patents: Hallin's latest patents include groundbreaking combination therapies for treating lung cancer. One notable invention involves the combination of palbociclib and adagrasib, which targets KRas G12C cancers. This invention outlines methods for administering a therapeutically effective amount of a CDK 4/6 inhibitor alongside a KRAS G12C inhibitor, along with pharmaceutical compositions and kits for effective treatment. Another patent focuses on combination therapies using a pan ErbB family inhibitor and a KRAS G12C inhibitor, further emphasizing her commitment to innovative cancer treatments.
Career Highlights: Jill Hallin is currently associated with Mirati Therapeutics, Inc., where she continues to push the boundaries of cancer research. Her work has not only contributed to the scientific community but has also provided hope for patients battling cancer.
Collaborations: Hallin collaborates with esteemed colleagues such as Ruth Wei Aranda and James Gail Christensen, enhancing the impact of her research through teamwork and shared expertise.
Conclusion: Jill Hallin's innovative work in cancer research exemplifies the vital role of inventors in advancing medical treatments. Her patents and collaborations reflect a commitment to improving patient outcomes and pushing the frontiers of science.